Skip to content
VuFind
    • English
    • Deutsch
    • Español
    • Français
    • Italiano
    • 日本語
    • Nederlands
    • Português
    • Português (Brasil)
    • 中文(简体)
    • 中文(繁體)
    • Türkçe
    • עברית
    • Gaeilge
    • Cymraeg
    • Ελληνικά
    • Català
    • Euskara
    • Русский
    • Čeština
    • Suomi
    • Svenska
    • polski
    • Dansk
    • slovenščina
    • اللغة العربية
    • বাংলা
    • Galego
    • Tiếng Việt
    • Hrvatski
    • हिंदी
    • Հայերէն
    • Українська
    • Sámegiella
    • Монгол
Advanced
  • Precision medicine in pantothe...
  • Cite this
  • Text this
  • Email this
  • Print
  • Export Record
    • Export to RefWorks
    • Export to EndNoteWeb
    • Export to EndNote
  • Permanent link
Precision medicine in pantothenate kinase-associated neurodegeneration

Precision medicine in pantothenate kinase-associated neurodegeneration

Neurodegeneration with brain iron accumulation is a broad term that describes a heterogeneous group of progressive and invalidating neurologic disorders in which iron deposits in certain brain areas, mainly the basal ganglia. The predominant clinical symptoms include spasticity, progressive dystonia...

Full description

Bibliographic Details
Main Authors: Mónica Alvarez-Cordoba, Marina Villanueva-Paz, Irene Villalón-García, Suleva Povea-Cabello, Juan M Suárez-Rivero, Marta Talaverón-Rey, Javier Abril-Jaramillo, Ana Belén Vintimilla-Tosi, José A Sánchez-Alcázar
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2019-01-01
Series:Neural Regeneration Research
Subjects:
neurodegeneration with brain iron accumulation; pantothenate kinase-associated neurodegeneration; pantothenate kinase 2; pantothenate; induced neurons; precision medicine; induced neuron; fibroblast
Online Access:http://www.nrronline.org/article.asp?issn=1673-5374;year=2019;volume=14;issue=7;spage=1177;epage=1185;aulast=Alvarez-Cordoba
  • Holdings
  • Description
  • Similar Items
  • Staff View

Internet

http://www.nrronline.org/article.asp?issn=1673-5374;year=2019;volume=14;issue=7;spage=1177;epage=1185;aulast=Alvarez-Cordoba

Similar Items

  • Down regulation of the expression of mitochondrial phosphopantetheinyl-proteins in pantothenate kinase-associated neurodegeneration: pathophysiological consequences and therapeutic perspectives
    by: Mónica Álvarez-Córdoba, et al.
    Published: (2021-05-01)
  • Therapeutic approach with commercial supplements for pantothenate kinase-associated neurodegeneration with residual PANK2 expression levels
    by: Mónica Álvarez-Córdoba, et al.
    Published: (2022-08-01)
  • Novel Compound Heterozygous Mutations in the Pantothenate Kinase 2 Gene in a Korean Patient with Atypical Pantothenate Kinase Associated Neurodegeneration
    by: Sung-Hyouk Kim, et al.
    Published: (2009-05-01)
  • Patient-Derived Cellular Models for Polytarget Precision Medicine in Pantothenate Kinase-Associated Neurodegeneration
    by: Mónica Álvarez-Córdoba, et al.
    Published: (2023-09-01)
  • Alpha-lipoic acid supplementation corrects pathological alterations in cellular models of pantothenate kinase-associated neurodegeneration with residual PANK2 expression levels
    by: Marta Talaverón-Rey, et al.
    Published: (2023-04-01)

Search Options

  • Search History
  • Advanced Search

Find More

  • Browse the Catalog
  • Browse Alphabetically
  • Explore Channels
  • Course Reserves
  • New Items

Need Help?

  • Search Tips
  • Ask a Librarian
  • FAQs